Published in Thorax on April 01, 2007
A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med (1997) 24.87
Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax (2003) 9.54
Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J (2006) 5.31
Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med (2006) 4.24
Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia. J Gen Intern Med (1995) 2.22
Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med (2005) 1.76
Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax (2004) 1.68
Assessment of pneumonia severity: a European perspective. Eur Respir J (2006) 1.63
A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax (2006) 1.62
CRB-65 predicts death from community-acquired pneumonia. J Intern Med (2006) 1.61
Predicting in-hospital mortality. A comparison of severity measurement approaches. Med Care (1992) 1.60
The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia. Thorax (2006) 1.53
Combining information from prognostic scoring tools for CAP: an American view on how to get the best of all worlds. Eur Respir J (2006) 1.40
Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax (2006) 1.35
Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia. Eur Respir J (2006) 1.00
Pneumonia: update on diagnosis and management. BMJ (2006) 3.69
Single versus combination antibiotic therapy in adults hospitalised with community acquired pneumonia. Thorax (2012) 2.81
Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial. Lancet Infect Dis (2010) 2.67
Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia. Thorax (2012) 2.17
Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults. Thorax (2011) 1.91
What is the role of pulse oximetry in the assessment of patients with community-acquired pneumonia in primary care? Prim Care Respir J (2010) 1.46
Differences between asthmatics and nonasthmatics hospitalised with influenza A infection. Eur Respir J (2012) 1.44
Bird flu and pandemic flu. BMJ (2005) 1.41
Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK. Thorax (2012) 1.40
Primary care summary of the British Thoracic Society Guidelines for the management of community acquired pneumonia in adults: 2009 update. Endorsed by the Royal College of General Practitioners and the Primary Care Respiratory Society UK. Prim Care Respir J (2010) 1.36
Nosocomial pandemic (H1N1) 2009, United Kingdom, 2009-2010. Emerg Infect Dis (2011) 0.98
Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations. Thorax (2011) 0.97
Pneumococcal serotypes in adult non-invasive and invasive pneumonia in relation to child contact and child vaccination status. Thorax (2013) 0.92
Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) disease. PLoS One (2011) 0.91
The comparative clinical course of pregnant and non-pregnant women hospitalised with influenza A(H1N1)pdm09 infection. PLoS One (2012) 0.87
Comparison of CATs, CURB-65 and PMEWS as triage tools in pandemic influenza admissions to UK hospitals: case control analysis using retrospective data. PLoS One (2012) 0.87
Preparing for the next flu pandemic. BMJ (2007) 0.86
Stridor in Crohn disease and the use of infliximab. Chest (2006) 0.80
The impact of an early chest radiograph on outcome in patients hospitalised with community-acquired pneumonia. Clin Med (2010) 0.79
The relevance of pneumococcal serotypes. Curr Infect Dis Rep (2014) 0.79
Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev (2016) 0.78
Tuberculosis and treatment with infliximab. N Engl J Med (2002) 0.78
An evaluation of community assessment tools (CATs) in predicting use of clinical interventions and severe outcomes during the A(H1N1)pdm09 pandemic. PLoS One (2013) 0.78
Community acquired pneumonia. Management in primary care. BMJ (2010) 0.77
Serotypes associated with the development of pneumococcal para-pneumonic effusion in adults. Eur Respir J (2012) 0.77
Pneumonia: let's avoid confusion of secondary and primary care issues in pneumonia. BMJ (2006) 0.75
The art of medicine: recognising influenza and pneumonia. Prim Care Respir J (2011) 0.75
Pandemic influenza--how would you and your hospital cope? Clin Med (2007) 0.75
From latent to active TB: are IGRAs of any use? Thorax (2016) 0.75
Diagnosis of community-acquired pneumonia in adults. Expert Rev Respir Med (2009) 0.75
Respiratory tract infections: uncommon pathogens and misleading presentations. Clin Med (2011) 0.75
Infection for the acute physician. Clin Med (2009) 0.75